{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:52:19Z","timestamp":1778586739260,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jviromet.2016.09.014","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T13:47:46Z","timestamp":1474292866000},"page":"192-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Platform for determining the inhibition profile of neuraminidase inhibitors in an influenza virus N1 background"],"prefix":"10.1016","volume":"237","author":[{"given":"Anja","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Schade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Kirchmair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Clement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Sauerbrei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Schmidtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2016.09.014_bib0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/135965350400900404","article-title":"A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A\/H1N1 virus","volume":"9","author":"Abed","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0010","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/135965350601100804","article-title":"Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds","volume":"11","author":"Abed","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0015","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1128\/JVI.02681-13","article-title":"Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A (H1N1) pdm09 virus in vitro, in mice and in ferrets","volume":"88","author":"Abed","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling","volume":"22","author":"Arnold","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jviromet.2016.09.014_bib0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/JVI.02485-14","article-title":"Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors","volume":"89","author":"Baek","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00430-011-0206-1","article-title":"Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008","volume":"201","author":"Bauer","year":"2012","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0035","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"Bloom","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2016.09.014_bib0040","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/jac\/dkq486","article-title":"Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness","volume":"66","author":"Brookes","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0045","first-page":"1472","article-title":"Multidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent child","volume":"17","author":"Eshaghi","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/molbev\/mst204","article-title":"Comparative dynamics and distribution of influenza drug resistance acquisition to protein M2 and neuraminidase inhibitors","volume":"31","author":"Garcia","year":"2014","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0055","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1073\/pnas.95.17.10224","article-title":"A novel mechanism for the acquisition of virulence by a human influenza A virus","volume":"95","author":"Goto","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/318537","article-title":"Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir","volume":"183","author":"Gubareva","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0065","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1002\/elps.200900140","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective","volume":"30","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jviromet.2016.09.014_bib0070","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0075","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01200-09","article-title":"Zanamivir-resistant influenza viruses with a novel neuraminidase mutation","volume":"83","author":"Hurt","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.antiviral.2010.06.009","article-title":"Assessing the development of oseltamivir and zanamivir resistance in A (H5N1) influenza viruses using a ferret model","volume":"87","author":"Hurt","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(11)70318-8","article-title":"Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives","volume":"12","author":"Hurt","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biologicals.2007.10.002","article-title":"Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity","volume":"36","author":"Kalbfuss","year":"2008","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2016.09.014_bib0100","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1021\/jm980162u","article-title":"Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors","volume":"41","author":"Kim","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0105","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.05.08026-en","article-title":"Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe","volume":"13","author":"Lackenby","year":"2008","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0110","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Avian flu: isolation of drug-resistant H5N1 virus","volume":"437","author":"Le","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2016.09.014_bib0115","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/AAC.42.3.647","article-title":"Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071","volume":"42","author":"Li","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0120","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/nsmb.1909","article-title":"The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site","volume":"17","author":"Li","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0125","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2015.20.45.30060","article-title":"Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring","volume":"20","author":"Little","year":"2015","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0130","doi-asserted-by":"crossref","first-page":"e71401","DOI":"10.1371\/journal.pone.0071401","article-title":"Determination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrate","volume":"8","author":"Marathe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2016.09.014_bib0135","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/jac\/dkt205","article-title":"Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase","volume":"68","author":"McKimm-Breschkin","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0140","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/jac\/dkt205","article-title":"Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase","volume":"68","author":"McKimm-Breschkin","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0145","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0150","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1021\/jm401977j","article-title":"Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors","volume":"57","author":"Mooney","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0155","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1128\/AAC.00581-10","article-title":"Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays","volume":"54","author":"Nguyen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"Nguyen","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.antiviral.2009.11.005","article-title":"Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses","volume":"85","author":"Okomo-Adhiambo","year":"2010","journal-title":"Antiviral Res."},{"issue":"Suppl. 1","key":"10.1016\/j.jviromet.2016.09.014_bib0170","first-page":"44","article-title":"Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors","volume":"7","author":"Okomo-Adhiambo","year":"2012","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.jviromet.2016.09.014_bib0175","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/INF.0b013e31825c7304","article-title":"Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses","volume":"31","author":"Rath","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0180","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoint","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2217\/fvl.14.97","article-title":"Complementary assays helping to overcome challenges for identifying neuraminidase inhibitors","volume":"10","author":"Richter","year":"2015","journal-title":"Future Virol."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0190","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/jm401492x","article-title":"Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A","volume":"57","author":"Schade","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0195","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1002\/jps.24508","article-title":"Zanamivir amidoxime- and N-hydroxyguanidine-based prodrug approaches to tackle poor oral bioavailability","volume":"104","author":"Schade","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0200","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0205","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1003749","article-title":"Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus","volume":"363","author":"van der Vries","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0210","doi-asserted-by":"crossref","first-page":"e1002914","DOI":"10.1371\/journal.ppat.1002914","article-title":"H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis","volume":"8","author":"van der Vries","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0215","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrd2400","article-title":"The war against influenza: discovery and development of sialidase inhibitors","volume":"6","author":"von Itzstein","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/nyas.12462","article-title":"Continuing challenges in influenza","volume":"1323","author":"Webster","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0225","series-title":"Clinical features of severe cases of pandemic influenza - Pandemic (H1N1) 2009 briefing note 13. World Health Organization Global Alert and Response","author":"WHO","year":"2009"},{"issue":"39","key":"10.1016\/j.jviromet.2016.09.014_bib0230","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility\u2014Geneva, November 2011 and June 2012;","volume":"87","author":"WHO","year":"2012","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0235","series-title":"World Health Organization Regional Office for Europe recommendations on influenza vaccination during the 2014\/2015 winter season","author":"WHO","year":"2014"},{"key":"10.1016\/j.jviromet.2016.09.014_bib0240","unstructured":"WHO, online. Laboratory methodologies for testing the antiviral susceptibility of influenza viruses: Neuraminidase inhibitor (NAI), Web. Jul 2016, http:\/\/www.who.int\/influenza\/gisrs_laboratory\/antiviral_susceptibility\/nai_phenotyping\/en\/."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0245","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/AAC.37.7.1473","article-title":"4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro","volume":"37","author":"Woods","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0250","doi-asserted-by":"crossref","first-page":"10493","DOI":"10.1128\/JVI.00959-08","article-title":"Structural characterization of the 1918 influenza virus H1N1 neuraminidase","volume":"82","author":"Xu","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2016.09.014_bib0255","doi-asserted-by":"crossref","first-page":"12418","DOI":"10.1128\/JVI.01067-07","article-title":"Neuraminidase inhibitor-resistant recombinant A\/Vietnam\/1203\/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo","volume":"81","author":"Yen","year":"2007","journal-title":"J. Virol."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093416302555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093416302555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T16:27:53Z","timestamp":1657297673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093416302555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":51,"alternative-id":["S0166093416302555"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2016.09.014","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platform for determining the inhibition profile of neuraminidase inhibitors in an influenza virus N1 background","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2016.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}